Ranibizumab versus bevacizumab for neovascular age-related macular degeneration: results from the GEFAL noninferiority randomized trial - Kodjikian, L; Souied, E H; Mimoun, G (Ophthalmology, 2013)
doi:10.1016/j.ophtha.2013.06.020